title: The Influence of an Obesogenic Diet on Oxysterol Metabolism in C57BL/6J Mice.
abstract: Our current understanding of oxysterol metabolism during different disease states such as obesity and dyslipidemia is limited. Therefore, the aim of this study was to determine the effect of diet-induced obesity on the tissue distribution of various oxysterols and the mRNA expression of key enzymes involved in oxysterol metabolism. To induce obesity, male C57BL/6J mice were fed a high fat-cholesterol diet for 24 weeks. Following diet-induced obesity, plasma levels of 4 β -hydroxycholesterol, 5,6 α -epoxycholesterol, 5,6 β -epoxycholesterol, 7 α -hydroxycholesterol, 7 β -hydroxycholesterol, and 27-hydroxycholesterol were significantly (P < 0.05) increased. In the liver and adipose tissue of the obese mice, 4 β -hydroxycholesterol was significantly (P < 0.05) increased, whereas 27-hydroxycholesterol was increased only in the adipose tissue. No significant changes in either hepatic or adipose tissue mRNA expression were observed for oxysterol synthesizing enzymes 4 β -hydroxylase, 27-hydroxylase, or 7 α -hydroxylase. Hepatic mRNA expression of SULT2B1b, a key enzyme involved in oxysterol detoxification, was significantly (P < 0.05) elevated in the obese mice. Interestingly, the appearance of the large HDL1 lipoprotein was observed with increased oxysterol synthesis during obesity. In diet-induced obese mice, dietary intake and endogenous enzymatic synthesis of oxysterols could not account for the increased oxysterol levels, suggesting that nonenzymatic cholesterol oxidation pathways may be responsible for the changes in oxysterol metabolism.
authors.affiliation: Division of Atherosclerosis and Vascular Medicine, Department of Medicine, Baylor College of Medicine, Houston, TX 77030, USA ; Department of Kinesiology and Health Education, Southern Illinois University Edwardsville, Campus Box 1126, Edwardsville, IL 62026-1126, USA.
authors.forename: Joshua S
authors.initials: JS
authors.lastname: Wooten
authors.affiliation: Division of Atherosclerosis and Vascular Medicine, Department of Medicine, Baylor College of Medicine, Houston, TX 77030, USA.
authors.forename: Huaizhu
authors.identifier: 0000-0001-6846-5531
authors.initials: H
authors.lastname: Wu
authors.affiliation: Division of Atherosclerosis and Vascular Medicine, Department of Medicine, Baylor College of Medicine, Houston, TX 77030, USA.
authors.forename: Joe
authors.identifier: 0000-0003-2718-7293
authors.initials: J
authors.lastname: Raya
authors.affiliation: Division of Atherosclerosis and Vascular Medicine, Department of Medicine, Baylor College of Medicine, Houston, TX 77030, USA.
authors.forename: Xiaoyuan Dai
authors.initials: XD
authors.lastname: Perrard
authors.affiliation: Division of Atherosclerosis and Vascular Medicine, Department of Medicine, Baylor College of Medicine, Houston, TX 77030, USA.
authors.forename: John
authors.identifier: 0000-0002-3176-5319
authors.initials: J
authors.lastname: Gaubatz
authors.affiliation: Division of Atherosclerosis and Vascular Medicine, Department of Medicine, Baylor College of Medicine, Houston, TX 77030, USA.
authors.forename: Ron C
authors.initials: RC
authors.lastname: Hoogeveen